337 related articles for article (PubMed ID: 21327254)
1. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
[TBL] [Abstract][Full Text] [Related]
2. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
[TBL] [Abstract][Full Text] [Related]
3. The O-β-linked N-acetylglucosaminylation of the Lamin B receptor and its impact on DNA binding and phosphorylation.
Smet-Nocca C; Page A; Cantrelle FX; Nikolakaki E; Landrieu I; Giannakouros T
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):825-835. PubMed ID: 29337275
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and
Cantrelle FX; Loyens A; Trivelli X; Reimann O; Despres C; Gandhi NS; Hackenberger CPR; Landrieu I; Smet-Nocca C
Front Mol Neurosci; 2021; 14():661368. PubMed ID: 34220449
[TBL] [Abstract][Full Text] [Related]
5. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation.
Wang Z; Pandey A; Hart GW
Mol Cell Proteomics; 2007 Aug; 6(8):1365-79. PubMed ID: 17507370
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
Ahmad W; Shabbiri K; Ahmad I
Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
[TBL] [Abstract][Full Text] [Related]
8. A genetic model to study
St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA
J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943
[No Abstract] [Full Text] [Related]
9. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
Ryu IH; Lee KY; Do SI
Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602
[TBL] [Abstract][Full Text] [Related]
10. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
[TBL] [Abstract][Full Text] [Related]
11. IP-LC-MSMS Enables Identification of Three Tau
Bijttebier S; Rodrigues Martins D; Mertens L; Grauwen K; Bruinzeel W; Willems R; Bartolomé-Nebreda JM; Theunis C; Bretteville A; Ebneth A; Dillen L
J Proteome Res; 2023 Apr; 22(4):1309-1321. PubMed ID: 36888912
[No Abstract] [Full Text] [Related]
12. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.
Lazarus BD; Love DC; Hanover JA
Glycobiology; 2006 May; 16(5):415-21. PubMed ID: 16434389
[TBL] [Abstract][Full Text] [Related]
13. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
[TBL] [Abstract][Full Text] [Related]
15. A peptide panel investigation reveals the acceptor specificity of O-GlcNAc transferase.
Liu X; Li L; Wang Y; Yan H; Ma X; Wang PG; Zhang L
FASEB J; 2014 Aug; 28(8):3362-72. PubMed ID: 24760753
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.
Cameron A; Giacomozzi B; Joyce J; Gray A; Graham D; Ousson S; Neny M; Beher D; Carlson G; O'Moore J; Shearman M; Hering H
FEBS Lett; 2013 Nov; 587(22):3722-8. PubMed ID: 24113653
[TBL] [Abstract][Full Text] [Related]
17. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
[TBL] [Abstract][Full Text] [Related]
18. Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes.
Kang MJ; Kim C; Jeong H; Cho BK; Ryou AL; Hwang D; Mook-Jung I; Yi EC
Exp Mol Med; 2013 Jun; 45(6):e29. PubMed ID: 23807304
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau.
Yu CH; Si T; Wu WH; Hu J; Du JT; Zhao YF; Li YM
Biochem Biophys Res Commun; 2008 Oct; 375(1):59-62. PubMed ID: 18671940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
